BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11156231)

  • 1. Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma.
    Oh MJ; Choi JH; Kim IH; Lee YH; Huh JY; Park YK; Lee KW; Chough SY; Joo KS; Ku BS; Saw HS
    Clin Cancer Res; 2000 Dec; 6(12):4760-3. PubMed ID: 11156231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
    Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
    Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.
    Souder C; Leitzel K; Ali SM; Demers L; Evans DB; Chaudri-Ross HA; Hackl W; Hamer P; Carney W; Lipton A
    Cancer; 2006 Nov; 107(10):2337-45. PubMed ID: 17048231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
    Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
    Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.
    Sandri MT; Johansson HA; Zorzino L; Salvatici M; Passerini R; Maisonneuve P; Rocca A; Peruzzotti G; Colleoni M
    Cancer; 2007 Aug; 110(3):509-17. PubMed ID: 17559147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of human epidermal growth factor receptor (hEGFR).
    Kumar RR; Meenakshi A; Sivakumar N
    Hum Antibodies; 2001; 10(3-4):143-7. PubMed ID: 11847425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
    Teknos TN; Cox C; Yoo S; Chepeha DB; Wolf GT; Bradford CR; Carey TE; Fisher SG
    Head Neck; 2002 Nov; 24(11):1004-11. PubMed ID: 12410536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer.
    Sasaki H; Yukiue H; Mizuno K; Sekimura A; Konishi A; Yano M; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    Int J Clin Oncol; 2003 Apr; 8(2):79-82. PubMed ID: 12720099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.
    Shariat SF; Bensalah K; Karam JA; Roehrborn CG; Gallina A; Lotan Y; Slawin KM; Karakiewicz PI
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5377-84. PubMed ID: 17875766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
    Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
    Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
    Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; Júnior AF; Ribeiro LF; Schmitt FC
    Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum epidermal growth factor receptor level in stage IV thymoma.
    Sasaki H; Yukiue H; Sekimura A; Mizuno K; Konishi A; Yano M; Fukai I; Fujii Y
    Surg Today; 2004; 34(5):477-9. PubMed ID: 15108095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic.
    Sung TI; Wang YJ; Chen CY; Hung TL; Guo HR
    Sci Total Environ; 2012 May; 424():74-8. PubMed ID: 22446113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.
    Merseburger AS; Hennenlotter J; Simon P; Kruck S; Koch E; Horstmann M; Kuehs U; Küfer R; Stenzl A; Kuczyk MA
    Anticancer Res; 2005; 25(3B):1901-7. PubMed ID: 16158924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients.
    Ravaggi A; Romani C; Pasinetti B; Tassi RA; Bignotti E; Bandiera E; Odicino FE; Ragnoli M; Donzelli C; Falchetti M; Calza S; Santin AD; Pecorelli S
    Arch Virol; 2006 Oct; 151(10):1899-916. PubMed ID: 16732494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.